Israel Englander’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $392K | Sell |
656,051
-985,195
| -60% | -$644K | ﹤0.01% | 4947 |
|
|
2026
Q1 | $1.28M | Buy |
+1,641,246
| New | +$1.39M | ﹤0.01% | 4204 |
|
|
2025
Q4 | – | Sell |
-1,890,921
| Closed | -$1.36M | – | 6564 |
|
|
2025
Q3 | $1.36M | Buy |
1,890,921
+290,721
| +18% | +$1.32M | ﹤0.01% | 4371 |
|
|
2025
Q2 | $8.11M | Buy |
1,600,200
+1,159
| +0.1% | +$4.56K | ﹤0.01% | 2488 |
|
|
2025
Q1 | $4.83M | Buy |
1,599,041
+1,231,052
| +335% | +$4.49M | ﹤0.01% | 2899 |
|
|
2024
Q4 | $1.33M | Buy |
367,989
+259,333
| +239% | +$785K | ﹤0.01% | 3966 |
|
|
2024
Q3 | $191K | Buy |
108,656
+2,224
| +2% | +$4.05K | ﹤0.01% | 5455 |
|
|
2024
Q2 | $166K | Buy |
106,432
+43,951
| +70% | +$76.5K | ﹤0.01% | 5204 |
|
|
2024
Q1 | $122K | Sell |
62,481
-62,745
| -50% | -$109K | ﹤0.01% | 5532 |
|
|
2023
Q4 | $177K | Buy |
125,226
+40,912
| +49% | +$52.5K | ﹤0.01% | 5217 |
|
|
2023
Q3 | $133K | Sell |
84,314
-267,790
| -76% | -$496K | ﹤0.01% | 5257 |
|
|
2023
Q2 | $761K | Buy |
+352,104
| New | +$769K | ﹤0.01% | 4243 |
|
|
2023
Q1 | – | Sell |
-68,106
| Closed | -$149K | – | 6961 |
|
|
2022
Q4 | $149K | Buy |
+68,106
| New | +$161K | ﹤0.01% | 5445 |
|
|
2022
Q1 | – | Sell |
-19,656
| Closed | -$147K | – | 7592 |
|
|
2021
Q4 | $147K | Sell |
19,656
-4,312
| -18% | -$36K | ﹤0.01% | 6084 |
|
|
2021
Q3 | $218K | Sell |
23,968
-6,418
| -21% | -$38.4K | ﹤0.01% | 6058 |
|
|
2021
Q2 | $148K | Buy |
+30,386
| New | +$129K | ﹤0.01% | 6123 |
|
|
2020
Q4 | – | Sell |
-22,771
| Closed | -$74 | – | 5653 |
|
|
2020
Q3 | $74 | Buy |
+22,771
| New | +$93.5K | ﹤0.01% | 4261 |
|
|
2020
Q2 | – | Sell |
-22,284
| Closed | -$62K | – | 4676 |
|
|
2020
Q1 | $62K | Buy |
+22,284
| New | +$96.2K | ﹤0.01% | 3639 |
|
|
2018
Q4 | – | Sell |
-2,302
| Closed | -$26K | – | 4254 |
|
|
2018
Q3 | $26K | Buy |
+2,302
| New | +$25.2K | ﹤0.01% | 3824 |
|
|
2018
Q1 | – | Sell |
-1,560
| Closed | -$76K | – | 4156 |
|
|
2017
Q4 | $76K | Buy |
+1,560
| New | +$95.9K | ﹤0.01% | 3694 |
|
|
2017
Q2 | – | Sell |
-2,102
| Closed | -$103K | – | 3934 |
|
|
2017
Q1 | $103K | Sell |
2,102
-1,269
| -38% | -$58K | ﹤0.01% | 3323 |
|
|
2016
Q4 | $101K | Sell |
3,371
-500
| -13% | -$20.5K | ﹤0.01% | 3192 |
|
|
2016
Q3 | $172K | Buy |
3,871
+339
| +10% | +$14.6K | ﹤0.01% | 3016 |
|
|
2016
Q2 | $137K | Buy |
+3,532
| New | +$164K | ﹤0.01% | 2976 |
|
|
2016
Q1 | – | Sell |
-1,192
| Closed | -$164K | – | 3730 |
|
|
2015
Q4 | $164K | Buy |
+1,192
| New | +$170K | ﹤0.01% | 3160 |
|
Other funds holding ATYR
GCP
KCM
Israel Englander's ATYR Position: Q2 2026 in Review
Israel Englander reduced its aTyr Pharma (ATYR) stake by 60% in Q2 2026, selling an estimated $644K and leaving 656,051 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #4947.
Israel Englander first reported a position in ATYR in Q4 2015 and has held it in 25 quarters since. The position peaked at $8.11M in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.
- Israel Englander held 656,051 shares of aTyr Pharma worth $392K as of Q2 2026.
- Israel Englander sold 985,195 aTyr Pharma shares in Q2 2026, an estimated $644K.
- aTyr Pharma made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4947 holding.
- Israel Englander first reported a position in aTyr Pharma in Q4 2015 and has held it in 25 quarters since.
- Israel Englander's aTyr Pharma position peaked at $8.11M in Q2 2025.
- 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.